Shahbazi Hamed bought NAGE
June 24, 2025 · Form 4 insider transaction
Shahbazi Hamed bought 20,000 shares of Niagen Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderShahbazi Hamed
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 24, 2025
Filing dateJuly 3, 2025
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option vests 100% on June 24, 2026.